Aytu BioScience, Inc. (AYTU) financial statements (2020 and earlier)

Company profile

Business Address 373 INVERNESS PARKWAY
ENGLEWOOD, CO 80112
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
8/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments71171970
Cash and cash equivalents71171870
Short-term investments    1  
Restricted cash and investments0000   
Receivables321100 
Inventory, net of allowances, customer advances and progress billings111110
Inventory111110 
Prepaid expense     0 
Other current assets0      
Other undisclosed current assets110000 
Total current assets:1215931080
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0001000
Intangible assets, net (including goodwill)000121
Goodwill   000 
Intangible assets, net (excluding goodwill)000121 
Deposits noncurrent assets000000 
Other noncurrent assets181911911  
Other undisclosed noncurrent assets   1190
Total noncurrent assets:1919121214100
TOTAL ASSETS:3135211524180
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4323410
Accounts payable3222  0
Accrued liabilities11010  
Interest and dividends payable      0
Other undisclosed accounts payable and accrued liabilities    41 
Debt0     0
Deferred rent credit  0
Due to related parties    5 0
Customer refund liability0      
Business combination, contingent consideration, liability1110  
Deferred revenue and credits   0 
Other undisclosed current liabilities111010(0)
Total current liabilities:65341010
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt22224741 
Deferred revenue and credits 000 
Deferred tax liabilities, net    0 
Business combination, contingent consideration, liability22224741
Derivative instruments and hedges, liabilities000 0  
Total noncurrent liabilities:23224741 
Total liabilities:29288111430
Stockholders' equity
Stockholders' equity attributable to parent, including:271341016(0)
Preferred stock00     
Common stock0000000
Common stock, value, subscriptions      0
Additional paid in capital114113937357390
Accumulated deficit(111)(106)(79)(69)(47)(18)(0)
Receivable from shareholders or affiliates for issuance of capital stock     (5) 
Other undisclosed stockholders' equity attributable to parent      (1)
Total stockholders' equity:271341016(0)
TOTAL LIABILITIES AND EQUITY:3135211524180

Income statement (P&L) ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
8/31/2013
Revenues7743300
Revenue, net  100
Cost of revenue(2)(2)(2)(1)(1)(0)(0)
Gross profit:552220(0)
Operating expenses(25)(24)(23)(23)(24)(8)(0)
Other undisclosed operating income (loss)22211(0) 
Operating loss:(18)(17)(20)(20)(22)(8)(0)
Nonoperating income (expense)(10)(10)10(2)(6) (0)
Investment income, nonoperating   (0)  (0)
Other nonoperating income 06    
Interest and debt expense(1)(1)(1)(3)(5) (0)
Loss from continuing operations before equity method investments, income taxes:(29)(28)(11)(25)(34)(8)(0)
Other undisclosed income (loss) from continuing operations before income taxes    5(0) 
Loss from continuing operations before income taxes:(29)(28)(11)(25)(28)(8)(0)
Income tax benefit     0 
Net loss:(29)(28)(11)(25)(28)(8)(0)
Other undisclosed net income attributable to parent1113  0
Net loss available to common stockholders, diluted:(29)(27)(10)(23)(28)(8)(0)

Comprehensive Income ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
8/31/2013
Net loss:(29)(28)(11)(25)(28)(8)(0)
Comprehensive loss, net of tax, attributable to parent:(29)(28)(11)(25)(28)(8)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: